MOXILASE-CV Dry Syrup: The 200mg + 28.5mg Combination in Focus

Choosing a suitable antibiotic formulation means looking beyond the brand name; it means understanding the active ingredients, strength, and dosage form. MOXILASE-CV Dry Syrup combines Amoxycillin 200mg + Potassium Clavulanate 28.5mg in a 30ml dry-syrup presentation with monocarton packaging.

This formulation brings an Amoxicillin-based antibacterial agent together with Clavulanate, a beta-lactamase inhibitor. The same 200mg/28.5mg composition is widely represented in Indian pharmaceutical listings as an oral dry-syrup formulation.

💡 The Formula in One Look

200mg Amoxycillin + 28.5mg Potassium Clavulanate = one combination dry syrup

Amoxycillin provides antibacterial activity, while Clavulanate helps inhibit certain beta-lactamase enzymes that can reduce the activity of some beta-lactam antibiotics.

MOXILASE-CV Product File

Where Can This Combination Be Relevant?

MOXILASE-CV Dry Syrup may be prescribed for selected bacterial infections when the Amoxycillin-Clavulanate combination is considered appropriate by a healthcare professional. Comparable 200mg/28.5mg dry-syrup formulations are listed for bacterial infections involving areas such as the ear, throat, chest, lungs, skin and urinary tract.

Five Common Clinical Areas

• Ear & Throat Infections — May be prescribed for appropriate susceptible bacterial ENT infections.

• Respiratory Infections — Can be considered for selected bacterial infections affecting the respiratory tract.

• Skin Infections — May be used for certain susceptible bacterial skin and soft-tissue infections.

• Urinary Tract Infections — Can be prescribed for appropriate susceptible bacterial urinary infections.

• Other Bacterial Infections — Selection depends on the suspected or confirmed organism and clinical assessment.

The key distinction: MOXILASE-CV is an antibacterial formulation, so it is not intended to treat viral infections such as the common cold.

Why Put These Two Ingredients Together?

The combination has a simple scientific logic.

Amoxycillin works by interfering with bacterial cell-wall formation, helping inhibit the growth of susceptible bacteria. Clavulanate inhibits certain beta-lactamase enzymes produced by bacteria, helping prevent those enzymes from inactivating Amoxycillin.

Ingredient-by-Ingredient

In simple words: Amoxycillin provides the antibacterial action, while Clavulanate helps overcome one of the bacterial mechanisms that can reduce the effectiveness of certain beta-lactam antibiotics.

From Powder to Oral Suspension

MOXILASE-CV is supplied as a dry syrup, meaning it needs to be prepared according to the manufacturer's instructions before administration.

The final dose should be determined by the prescribing healthcare professional. Particularly for children, the appropriate dose may depend on body weight, age, infection severity, kidney function, and the specific formulation.

A Better Way to Handle the Dose

01 — Prepare correctly
Reconstitute the dry syrup exactly according to the product instructions.

02 — Mix before dosing
Shake the prepared suspension well before each administration.

03 — Measure accurately
Use a suitable oral measuring device rather than estimating with a household spoon.

04 — Follow the prescription
Use the prescribed dose at the recommended intervals.

05 — Finish as directed
Do not discontinue antibiotic treatment early unless instructed by the healthcare professional.

Dosage warning: Never calculate a child's antibiotic dose from age alone. The appropriate dose should be confirmed by a qualified healthcare professional.

Good antibiotic use starts with the right dose, not an assumed dose.

Know the Difference Between Common & Concerning Reactions

Amoxicillin + Potassium Clavulanate may cause side effects in some individuals. Common reactions are generally gastrointestinal, while severe allergic, skin or other unusual reactions require prompt medical attention. Comparable 200mg/28.5mg products commonly list diarrhoea, nausea and vomiting among possible side effects.

🟡 Commonly Reported

🔴 Serious or Rare

Safety signal: Severe, persistent, or rapidly worsening symptoms should receive medical attention.

Five Checks Before Treatment

1. Allergy Check

Tell your healthcare professional about any previous penicillin or related antibiotic allergy.

2. Kidney Check

Patients with kidney impairment may require individualized dosing.

3. Liver History

Disclose previous liver disease or previous liver-related reactions associated with antibiotics.

4. Medicine Check

Inform the prescriber about current prescription medicines, OTC medicines, and supplements.

5. Antibiotic Check

Do not self-medicate, share antibiotics, or reuse leftover antibiotics.

One simple rule: Your medical history matters as much as the medicine itself.

Add a High-Demand Formulation to Your Pharma Growth Plan

The right product can open new opportunities for a growing pharmaceutical business. MOXILASE-CV Dry Syrup, formulated with Amoxycillin 200mg + Potassium Clavulanate 28.5mg, offers eligible pharma businesses an opportunity to strengthen their antibacterial product portfolio with a defined oral dry-syrup formulation.

Why Explore This Product?

• Defined Combination – Amoxycillin 200mg + Potassium Clavulanate 28.5mg.

• Portfolio Expansion – Suitable for businesses looking to broaden their pharmaceutical range.

• Multiple Business Models – Explore PCD Pharma Franchise and other partnership options.

• Market Development – Support opportunities across different markets and territories.

Build Your Pharma Business With Monark Biocare

Monark Biocare provides business solutions including PCD Pharma Franchise, Third Party Manufacturing, Ethical Promotion, Export Medicines, Contract Manufacturing, Private Label Manufacturing, and more.

Ready for the next step? Connect with Monark Biocare to explore MOXILASE-CV Dry Syrup, product requirements, partnership opportunities, and market expansion possibilities.

Disclaimer

This content is for general product awareness and does not replace medical advice. MOXILASE-CV Dry Syrup should be used only under the direction of a qualified healthcare professional. Dosage and treatment duration depend on individual clinical requirements.

MOXILASE-CV: Straight Answers

01. What is MOXILASE-CV Dry Syrup?

MOXILASE-CV Dry Syrup contains Amoxycillin 200mg + Potassium Clavulanate 28.5mg and is supplied as a 30ml dry-syrup formulation with monocarton packaging.

02. What is the 200mg/28.5mg combination used for?

It may be prescribed for selected bacterial infections involving areas such as the respiratory tract, ear, throat, skin and urinary tract when the combination is clinically appropriate.

03. What does Potassium Clavulanate do?

It helps inhibit certain beta-lactamase enzymes, supporting the activity of Amoxycillin against susceptible organisms.

04. Is MOXILASE-CV a ready-to-use syrup?

It is supplied as a dry syrup and therefore requires appropriate reconstitution before administration according to the manufacturer's instructions.

05. Can MOXILASE-CV be used without a prescription?

No. It is an antibiotic formulation and should be used only when a qualified healthcare professional determines that it is appropriate.